Enantyum® IV Versus Piroxen® IM in Emergency Pain Management

Launched by RIADH BOUKEF · May 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two different pain relief medications, Enantyum® (dexketoprofen) given through an IV and Piroxen® (piroxicam) given through an injection, for people experiencing pain from traumatic injuries in emergency departments. The goal is to see which medication works better for managing this type of pain. The trial is currently looking for participants aged 18 and older who need pain relief for recent injuries and are willing to provide consent to join the study.

To be eligible, participants should not have chronic pain, certain medical conditions like liver cirrhosis, or known allergies to the medications being tested. They also should not be pregnant or unable to give consent. If you join the trial, you can expect to receive one of the two medications and be monitored for how well it helps reduce your pain. This study aims to provide better evidence on effective pain management options in emergency situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years of age who required analgesia for acute pain of traumatic origin and who signed a written consent form were included in the study.
• Exclusion Criteria:
• * Patients who meet the following conditions:
• • refusal, incapacity, difficulties with consent or communication
• • Patients with chronic pain.
• • Any known allergy or secondary reaction to piroxen or dexketoprofen trometamol.
• • Pregnant women.
• • Cirrhosis of the liver.